{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:23:22Z","timestamp":1792887802366,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.arcped.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T22:02:13Z","timestamp":1700517733000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlations between clinical motor scores and CMAP in patients with type 2 spinal muscular amyotrophy treated with nusinersen"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-0606","authenticated-orcid":false,"given":"M.","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Barrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Desguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Deladri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Leloup-Germa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Barnerias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gitiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2023.08.011_bib0001","first-page":"2120\u201133","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.arcped.2023.08.011_bib0002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13023-020-01414-8","article-title":"Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study","volume":"15","author":"Audic","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"17","key":"10.1016\/j.arcped.2023.08.011_bib0003","first-page":"41","article-title":"Health & Medicine pr\u00e9sent\u00e9 \u00e0","volume":"16","year":"2021","journal-title":"Disponible sur"},{"key":"10.1016\/j.arcped.2023.08.011_bib0004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/B978-0-444-64076-5.00038-7","article-title":"Spinal muscular atrophy","volume":"148","author":"Arnold","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.arcped.2023.08.011_bib0005","first-page":"562","article-title":"Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides","volume":"2","author":"Geary","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.arcped.2023.08.011_bib0006","doi-asserted-by":"crossref","first-page":"443\u201152","DOI":"10.1016\/S1474-4422(12)70061-3","article-title":"Childhood spinal muscular atrophy: controversies and challenges","volume":"11","author":"Mercuri","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.arcped.2023.08.011_bib0007","article-title":"Orphanet: amyotrophie spinale proximale type 4 [Internet]","author":"RESERVES","year":"2022","journal-title":"Disponible sur"},{"key":"10.1016\/j.arcped.2023.08.011_bib0008","doi-asserted-by":"crossref","first-page":"103\u201115","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2023.08.011_bib0009","doi-asserted-by":"crossref","first-page":"596\u2011605","DOI":"10.1016\/j.nmd.2017.02.014","article-title":"218th ENMC international workshop:: revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19\u201321 February 2016","volume":"27","author":"Finkel","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2023.08.011_bib0010","first-page":"593\u2011602","volume":"25","author":"Finkel","year":"2015"},{"key":"10.1016\/j.arcped.2023.08.011_bib0011","doi-asserted-by":"crossref","first-page":"890\u20117","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2023.08.011_bib0012","doi-asserted-by":"crossref","first-page":"3017\u201126","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2023.08.011_bib0013","doi-asserted-by":"crossref","first-page":"625\u201135","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2023.08.011_bib0014","doi-asserted-by":"crossref","first-page":"1723\u201132","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2023.08.011_bib0015","doi-asserted-by":"crossref","first-page":"883\u201191","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcped.2023.08.011_bib0016","doi-asserted-by":"crossref","first-page":"642\u20117","DOI":"10.1002\/mus.23233","article-title":"Electrical impedance myography in spinal muscular atrophy: a longitudinal study","volume":"45","author":"Rutkove","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2023.08.011_bib0017","doi-asserted-by":"crossref","first-page":"703\u20118","DOI":"10.1002\/mus.21838","article-title":"Compound muscle action potential and motor function in children with spinal muscular atrophy","volume":"42","author":"Lewelt","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2023.08.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007527","article-title":"Nusinersen in later-onset spinal muscular atrophy: long-term results from the phase 1\/2 studies","volume":"92","author":"Darras","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2023.08.011_bib0019","first-page":"2218\u201126","article-title":"Motor function measure: validation of a short form for young children with neuromuscular diseases","volume":"94","author":"de","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.arcped.2023.08.011_bib0020","doi-asserted-by":"crossref","first-page":"463\u201170","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"A motor function measure scale for neuromuscular diseases. Construction and validation study","volume":"15","author":"B\u00e9rard","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2023.08.011_bib0021","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.apmr.2014.05.003","article-title":"English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases","volume":"95","author":"Vuillerot","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.arcped.2023.08.011_bib0022","doi-asserted-by":"crossref","first-page":"443\u201151","DOI":"10.1002\/ana.25533","article-title":"Nusinersen in type 1 spinal muscular atrophy: twelve-month real-world data","volume":"86","author":"Pane","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcped.2023.08.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006281","article-title":"Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: a cohort study","volume":"91","author":"Aragon-Gawinska","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2023.08.011_bib0024","doi-asserted-by":"crossref","first-page":"122\u20117","DOI":"10.1016\/j.ejpn.2017.11.001","article-title":"Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1","volume":"22","author":"Pechmann","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.arcped.2023.08.011_bib0025","doi-asserted-by":"crossref","first-page":"1555\u201161","DOI":"10.1016\/j.apmr.2013.01.014","article-title":"MFM Spinal Muscular Atrophy Study Group. Responsiveness of the motor function measure in patients with spinal muscular atrophy","volume":"94","author":"Vuillerot","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.arcped.2023.08.011_bib0026","doi-asserted-by":"crossref","first-page":"309\u201114","DOI":"10.1016\/j.nmd.2023.02.004","article-title":"A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy","volume":"33","author":"Barrois","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.arcped.2023.08.011_bib0027","doi-asserted-by":"crossref","first-page":"445\u201153","DOI":"10.1002\/mus.27372","article-title":"Motor unit number index: a potential electrophysiological biomarker for pediatric spinal muscular atrophy","volume":"64","author":"Boulay","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arcped.2023.08.011_bib0028","doi-asserted-by":"crossref","first-page":"175\u20116","DOI":"10.4103\/0972-2327.99700","article-title":"The split hand sign","volume":"15","author":"Benny","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.arcped.2023.08.011_bib0029","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp-2020-324254","article-title":"Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen","volume":"92","author":"Kariyawasam","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X23001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X23001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:57:29Z","timestamp":1760540249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X23001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0929693X23001720"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2023.08.011","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations between clinical motor scores and CMAP in patients with type 2 spinal muscular amyotrophy treated with nusinersen","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}